Malin Jarvius

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Cancer intrinsic protein neddylation modulates the intra-tumoral immune landscape to constrain immune checkpoint blockade therapy.

Cancer intrinsic protein neddylation modulates the intra-tumoral immune landscape to constrain immune checkpoint blockade therapy.

Journal: Cancer immunology research
Published: October 20, 2025

Exploratory insights from the immuno-oncology hollow fiber assay: A pilot approach bridging In Vitro and In Vivo models.

Exploratory insights from the immuno-oncology hollow fiber assay: A pilot approach bridging In Vitro and In Vivo models.

Journal: SLAS technology
Published: October 15, 2024

The method developer's guide to oligonucleotide design.

The method developer's guide to oligonucleotide design.

Journal: Expert review of proteomics
Published: February 16, 2024

Discovery of a novel inhibitor of macropinocytosis with antiviral activity.

Discovery of a novel inhibitor of macropinocytosis with antiviral activity.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 16, 2024

Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment.

Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment.

Journal: BMC pharmacology & toxicology
Published: July 05, 2023

Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death.

Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death.

Journal: BMC cancer
Published: November 07, 2022

Single-cell transcriptional pharmacodynamics of trifluridine in a tumor-immune model.

Single-cell transcriptional pharmacodynamics of trifluridine in a tumor-immune model.

Journal: Scientific reports
Published: February 25, 2022

Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma.

Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma.

Journal: Scientific reports
Published: December 16, 2021

Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survival.

Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survival.

Journal: Nature communications
Published: February 06, 2021

Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress.

Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress.

Journal: Nature cancer
Published: January 12, 2021

Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway.

Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway.

Journal: Scientific reports
Published: December 03, 2019

Mesenchymal transition and increased therapy resistance of glioblastoma cells is related to astrocyte reactivity.

Mesenchymal transition and increased therapy resistance of glioblastoma cells is related to astrocyte reactivity.

Journal: The Journal of pathology
Published: January 23, 2019
Showing 1-12 of 28

Last Updated: 09/26/2026